风雪腊梅
2021-05-25

???

高盛上调石药(01093.HK)目标价至13.5元 评级「买入」

高盛发表报告，将石药集团 2021至2023年各年净利润预测分别上调7.6%、4.2%、5.9%，以分类加总估值法计，将目标价由12.5元提高至13.5元，评级「买入」，包括创新药估值由1,110亿元下调至859亿元，以反映新药降价的影响，不过仿制药估值就由240亿元上调至520亿元，因随着更多新的非专利药通过带量采购获得市场份额，令相关业务增长前景将得到改善。而考虑到疫情期间价格上涨，原料药估值由140亿元上调至230亿元。
高盛上调石药(01093.HK)目标价至13.5元 评级「买入」

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet